Uploaded July 2026 | Updated September 2026, 2 weeks ago
Once a month we answer Barbell Medicine Plus subscribers’ questions on the Direct Line. This is a free look at June’s episode. We start with GLP-1 drugs and muscle: why DEXA overstates the loss, what resistance training actually does, and whether creatine is worth taking. Then whether bulking and cutting does anything the scale can’t already tell you, how to get real benefit from one training hour a week, and what happens to your muscle, strength, tendons, and bone when you take time off, including why muscle memory brings it back faster than you built it.
What we cover:
• GLP-1s and muscle: the DEXA problem, resistance training, and creatine
• Bulking vs cutting vs just maintaining, and a health-first way to choose
• Training on one hour a week: the least that still moves the needle
• How fast you lose muscle when you stop, and why it comes back fast
The full two-hour episode and every back episode are on Barbell Medicine Plus, which can bundled with Premium. Resources and full references below.
Timestamps
0:00 Intro + GLP-1 and the DEXA muscle-loss myth
3:00 Do GLP-1s spare or waste muscle?
8:03 Does creatine help on a GLP-1?
10:45 Does bulking and cutting do anything?
13:18 Health first: when to lose fat before gaining
22:30 Training on one hour a week
36:22 How fast you lose muscle when you stop
43:19 Muscle memory: why it comes back
48:25 The full episode on Plus
Resources
• Barbell Medicine coaching and templates: barbellmedicine.com
• barbellmedicine.com/shop/subscriptions/plus-podcast-subscription
• barbellmedicine.com/shop/subscriptions/barbell-medicine-premium
• Signal book pre-order: barbellmedicine.com/shop/learning/signal
•
barbellmedicine.com/blog/glp-1-muscle-loss
barbellmedicine.com/blog/creatine-on-ozempic-does-it-prevent-muscle-loss
barbellmedicine.com/blog/novice-intermediate-advanced-strength-training
Lundgren JR, et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (S-LITE). N Engl J Med 2021;384:1719-1730. nejm.org · NEJMoa2028198 (nejm.org/doi/10.1056/NEJMoa2028198)
T-REX trial: tirzepatide with or without resistance training (Univ. of Western Australia). Preliminary. ANZCTR ACTRN12623001236684 (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385806)
Creatine + GLP-1 pilot (Univ. of Saskatchewan). Ongoing, results expected 2027. ClinicalTrials.gov NCT07625202 (clinicaltrials.gov/study/NCT07625202)
Momma H, et al. Muscle-strengthening activities and lower risk/mortality in major non-communicable diseases. Br J Sports Med 2022. PubMed 35228201 (pubmed.ncbi.nlm.nih.gov/35228201/)
Wall BT, et al. 2014. Immobilization and disuse muscle atrophy (quadriceps −3.5% at 5 days, −8% at 14 days). PubMed 24168489 (pubmed.ncbi.nlm.nih.gov/24168489/)
Gaffney CJ, et al. 2021. Grip strength loss with short-term arm immobilization. PMC8107283 (ncbi.nlm.nih.gov/pmc/articles/PMC8107283/)
Farthing JP, et al. 2009. Cross-education and preservation of the immobilized limb. PubMed 19150859 (pubmed.ncbi.nlm.nih.gov/19150859/)
Marusic U, et al. 2021. Bed rest: strength loss outpaces size loss. PMC8325614 (ncbi.nlm.nih.gov/pmc/articles/PMC8325614/)
Yoshihara, et al. 2023. Sepsis-associated muscle wasting (−26% in a week). PMC10003568 (ncbi.nlm.nih.gov/pmc/articles/PMC10003568/)
Warren GL, et al. 2017. Strength loss and recovery after muscle injury (meta-analysis). PMC5214801 (ncbi.nlm.nih.gov/pmc/articles/PMC5214801/)
Hortobágyi T, et al. 1993. Short-term detraining in strength athletes. PubMed 8371654 (pubmed.ncbi.nlm.nih.gov/8371654/)
Gavanda S, et al. 2020. Training cessation in previously untrained adolescents. PMC7241623 (ncbi.nlm.nih.gov/pmc/articles/PMC7241623/)
Lovell DI, et al. 2010. Detraining strength loss in older adults. PubMed 20140683 (pubmed.ncbi.nlm.nih.gov/20140683/)
Mujika I, Padilla S. 2001. Physiology of detraining (review). PubMed 11474330 (pubmed.ncbi.nlm.nih.gov/11474330/)
Smith K, et al. 2003. Two years of training, then detraining, in older adults. PubMed 12955872 (pubmed.ncbi.nlm.nih.gov/12955872/)
Staron RS, et al. 1991. Detraining and muscle cross-sectional area in women. PubMed 1827108 (pubmed.ncbi.nlm.nih.gov/1827108/)
Ivey FM, et al. 2000. Detraining across age and sex. PubMed 10795719 (pubmed.ncbi.nlm.nih.gov/10795719/)
Taaffe DR, et al. 2009. Training and detraining in older adults. PMC2756799 (ncbi.nlm.nih.gov/pmc/articles/PMC2756799/)
Grgic J, et al. 2022. Muscle size loss with detraining (meta-analysis). PubMed 36360927 (pubmed.ncbi.nlm.nih.gov/36360927/)
Bosquet L, et al. 2013. Detraining effects on strength and power. PubMed 2334705...
Once a month we answer Barbell Medicine Plus subscribers’ questions on the Direct Line. This is a free look at June’s episode. We start with GLP-1 drugs and muscle: why DEXA overstates the loss, what resistance training actually does, and whether creatine is worth taking. Then whether bulking and cutting does anything the scale can’t already tell you, how to get real benefit from one training hour a week, and what happens to your muscle, strength, tendons, and bone when you take time off, including why muscle memory brings it back faster than you built it.
What we cover:
• GLP-1s and muscle: the DEXA problem, resistance training, and creatine
• Bulking vs cutting vs just maintaining, and a health-first way to choose
• Training on one hour a week: the least that still moves the needle
• How fast you lose muscle when you stop, and why it comes back fast
The full two-hour episode and every back episode are on Barbell Medicine Plus, which can bundled with Premium. Resources and full references below.
Timestamps
0:00 Intro + GLP-1 and the DEXA muscle-loss myth
3:00 Do GLP-1s spare or waste muscle?
8:03 Does creatine help on a GLP-1?
10:45 Does bulking and cutting do anything?
13:18 Health first: when to lose fat before gaining
22:30 Training on one hour a week
36:22 How fast you lose muscle when you stop
43:19 Muscle memory: why it comes back
48:25 The full episode on Plus
Resources
• Barbell Medicine coaching and templates: barbellmedicine.com
• barbellmedicine.com/shop/subscriptions/plus-podcast-subscription
• barbellmedicine.com/shop/subscriptions/barbell-medicine-premium
• Signal book pre-order: barbellmedicine.com/shop/learning/signal
•
barbellmedicine.com/blog/glp-1-muscle-loss
barbellmedicine.com/blog/creatine-on-ozempic-does-it-prevent-muscle-loss
barbellmedicine.com/blog/novice-intermediate-advanced-strength-training
Lundgren JR, et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (S-LITE). N Engl J Med 2021;384:1719-1730. nejm.org · NEJMoa2028198 (nejm.org/doi/10.1056/NEJMoa2028198)
T-REX trial: tirzepatide with or without resistance training (Univ. of Western Australia). Preliminary. ANZCTR ACTRN12623001236684 (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385806)
Creatine + GLP-1 pilot (Univ. of Saskatchewan). Ongoing, results expected 2027. ClinicalTrials.gov NCT07625202 (clinicaltrials.gov/study/NCT07625202)
Momma H, et al. Muscle-strengthening activities and lower risk/mortality in major non-communicable diseases. Br J Sports Med 2022. PubMed 35228201 (pubmed.ncbi.nlm.nih.gov/35228201/)
Wall BT, et al. 2014. Immobilization and disuse muscle atrophy (quadriceps −3.5% at 5 days, −8% at 14 days). PubMed 24168489 (pubmed.ncbi.nlm.nih.gov/24168489/)
Gaffney CJ, et al. 2021. Grip strength loss with short-term arm immobilization. PMC8107283 (ncbi.nlm.nih.gov/pmc/articles/PMC8107283/)
Farthing JP, et al. 2009. Cross-education and preservation of the immobilized limb. PubMed 19150859 (pubmed.ncbi.nlm.nih.gov/19150859/)
Marusic U, et al. 2021. Bed rest: strength loss outpaces size loss. PMC8325614 (ncbi.nlm.nih.gov/pmc/articles/PMC8325614/)
Yoshihara, et al. 2023. Sepsis-associated muscle wasting (−26% in a week). PMC10003568 (ncbi.nlm.nih.gov/pmc/articles/PMC10003568/)
Warren GL, et al. 2017. Strength loss and recovery after muscle injury (meta-analysis). PMC5214801 (ncbi.nlm.nih.gov/pmc/articles/PMC5214801/)
Hortobágyi T, et al. 1993. Short-term detraining in strength athletes. PubMed 8371654 (pubmed.ncbi.nlm.nih.gov/8371654/)
Gavanda S, et al. 2020. Training cessation in previously untrained adolescents. PMC7241623 (ncbi.nlm.nih.gov/pmc/articles/PMC7241623/)
Lovell DI, et al. 2010. Detraining strength loss in older adults. PubMed 20140683 (pubmed.ncbi.nlm.nih.gov/20140683/)
Mujika I, Padilla S. 2001. Physiology of detraining (review). PubMed 11474330 (pubmed.ncbi.nlm.nih.gov/11474330/)
Smith K, et al. 2003. Two years of training, then detraining, in older adults. PubMed 12955872 (pubmed.ncbi.nlm.nih.gov/12955872/)
Staron RS, et al. 1991. Detraining and muscle cross-sectional area in women. PubMed 1827108 (pubmed.ncbi.nlm.nih.gov/1827108/)
Ivey FM, et al. 2000. Detraining across age and sex. PubMed 10795719 (pubmed.ncbi.nlm.nih.gov/10795719/)
Taaffe DR, et al. 2009. Training and detraining in older adults. PMC2756799 (ncbi.nlm.nih.gov/pmc/articles/PMC2756799/)
Grgic J, et al. 2022. Muscle size loss with detraining (meta-analysis). PubMed 36360927 (pubmed.ncbi.nlm.nih.gov/36360927/)
Bosquet L, et al. 2013. Detraining effects on strength and power. PubMed 2334705...





![Does Training Frequency Matter for Strength and Size?
If you have three lifts planned for the day but split them hours apart, are you leaving strength and size on the table? The short answer from Jordan and Dr. Austin Baraki: it is fine. The longer answer is a useful window into how they think about programming.
Frequency is a tool to distribute training load, not an independent driver of adaptation. When you equate volume, the frequency signal mostly disappears: Schoenfeld’s 2016 meta-analysis showed a small hypertrophy edge for higher frequency, but the volume was not actually equated, and the 2019 update with 25 studies erased the difference. Strength data tell the same story. Where Jordan goes slightly beyond the evidence: he suspects splitting volume up lets you accumulate more total training load over months and years because you lift fresher, and that higher-skill lifts like the overhead press may benefit from frequent, low-fatigue exposure.
They extend the same logic to cardiorespiratory fitness, where the old 10-minute bout minimum has been dropped entirely, while still arguing that some longer sessions matter if maximizing fitness is the goal. The practical takeaway: distribute your training by preference and logistics, prioritize adherence, and do not worry that splitting a session hurts your results. Full AMA episode and references linked below.
Resources:
Subscribe to BBM Plus for the full unabridged Direct Line: https://barbellmedicine.supercast.com/
Barbell Medicine coaching and templates: https://www.barbellmedicine.com/
Signal book pre-order: https://www.barbellmedicine.com/shop/learning/signal/
Schoenfeld B.J. et al. 2016. Effects of resistance training frequency on measures of muscle hypertrophy: a systematic review and meta-analysis. Sports Med 46(11):1689-1697.
https://pubmed.ncbi.nlm.nih.gov/27102172/
Schoenfeld B.J. et al. 2019. How many times per week should a muscle be trained to maximize hypertrophy? J Sports Sci 37(11):1286-1295.
https://pubmed.ncbi.nlm.nih.gov/30558493/
Becker T. et al. 2022. Resistance training frequency and strength outcomes: meta-analysis. [verify] Does Training Frequency Matter for Strength and Size?](https://i.ytimg.com/vi/aUL6twnRME8/mqdefault.jpg)


![They Removed the Tumor and the Weight Got Worse: Acquired Hypothalamic Obesity
The surgery works, the tumor is gone, the hormones are replaced, and the patient gains weight faster than before. This segment explains why: the operation touched the circuit that sets body weight. We walk the POMC brake and the AgRP accelerator, and set the record straight on leptin.
Timestamps:
00:00:00 The name: a tumor built from tooth tissue
00:00:18 Surgery, and what it costs
00:02:11 The new mystery: gaining weight faster than ever
00:08:09 The diagnosis: acquired hypothalamic obesity
00:13:45 How the brain sets weight: the brake and the accelerator
00:16:35 What about leptin?
Resources
Barbell Medicine coaching and templates: https://www.barbellmedicine.com
Plus podcast subscription: https://www.barbellmedicine.com/shop/subscriptions/plus-podcast-subscription/
Barbell Medicine Premium: https://www.barbellmedicine.com/shop/subscriptions/barbell-medicine-premium/
Signal (book pre-order): https://www.barbellmedicine.com/shop/learning/signal/
1. Brijmohan A, et al. Acquired hypothalamic obesity following craniopharyngioma resection in a young adult [case report]. 2025. PMCID: PMC12268545; PMID: 40677794.
2. Miller JL, et al; TRANSCEND investigators. Setmelanotide in acquired hypothalamic obesity: a phase 3 randomized trial. N Engl J Med. 2026.
3. Rhythm Pharmaceuticals. FDA approves IMCIVREE (setmelanotide) for acquired hypothalamic obesity. News release. March 19, 2026.
4. US Food and Drug Administration. FDA approves first treatment for weight management for people with certain rare genetic conditions (setmelanotide). 2020.
5. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-908.
6. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341(12):879-884.
7. Krude H, Biebermann H, Luck W, et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19(2):155-157.
8. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085-1095.
9. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392(6674):398-401.
10. Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139(2):448-455.
11. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549-2557.
12. Guyenet SJ. The Hungry Brain: Outsmarting the Instincts That Make Us Overeat. Flatiron Books; 2017. They Removed the Tumor and the Weight Got Worse: Acquired Hypothalamic Obesity](https://i.ytimg.com/vi/bHZa0G-JDfk/mqdefault.jpg)

